

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.70809283 |
| 2 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.61673067 |
| 3 | cell communication by electrical coupling (GO:0010644) | 4.40904308 |
| 4 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.37700762 |
| 5 | cardiac myofibril assembly (GO:0055003) | 4.31549830 |
| 6 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.11051440 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.08526123 |
| 8 | protein carboxylation (GO:0018214) | 4.08526123 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 4.08398087 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.03463923 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.93155318 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.87155979 |
| 13 | cell communication involved in cardiac conduction (GO:0086065) | 3.85764448 |
| 14 | regulation of fibrinolysis (GO:0051917) | 3.77319816 |
| 15 | plasma membrane repair (GO:0001778) | 3.73442705 |
| 16 | intestinal cholesterol absorption (GO:0030299) | 3.71373147 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.70618139 |
| 18 | regulation of plasminogen activation (GO:0010755) | 3.69305104 |
| 19 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67848340 |
| 20 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63638608 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.57174601 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.55981963 |
| 23 | regulation of membrane repolarization (GO:0060306) | 3.54148259 |
| 24 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.50360109 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.47522170 |
| 26 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.45437128 |
| 27 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.43466560 |
| 28 | regulation of protein activation cascade (GO:2000257) | 3.42291757 |
| 29 | vocalization behavior (GO:0071625) | 3.41069092 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.39984626 |
| 31 | locomotory exploration behavior (GO:0035641) | 3.39858810 |
| 32 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.36932740 |
| 33 | myofibril assembly (GO:0030239) | 3.36774802 |
| 34 | regulation of complement activation (GO:0030449) | 3.33663071 |
| 35 | sarcomere organization (GO:0045214) | 3.32425202 |
| 36 | cardiac muscle contraction (GO:0060048) | 3.27508070 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.26583062 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.23144964 |
| 39 | sodium ion export (GO:0071436) | 3.19793833 |
| 40 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.19376424 |
| 41 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.18469742 |
| 42 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.16513910 |
| 43 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.16362374 |
| 44 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.11533917 |
| 45 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.10700227 |
| 46 | plasma lipoprotein particle assembly (GO:0034377) | 3.09555201 |
| 47 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.08823470 |
| 48 | cell migration in hindbrain (GO:0021535) | 3.07827401 |
| 49 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.04528441 |
| 50 | chondrocyte proliferation (GO:0035988) | 3.04388412 |
| 51 | establishment of nucleus localization (GO:0040023) | 3.02796065 |
| 52 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.97512439 |
| 53 | axonal fasciculation (GO:0007413) | 2.94822435 |
| 54 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94644310 |
| 55 | negative regulation of protein activation cascade (GO:2000258) | 2.93880915 |
| 56 | membrane depolarization during action potential (GO:0086010) | 2.92556576 |
| 57 | low-density lipoprotein particle remodeling (GO:0034374) | 2.92122663 |
| 58 | dendrite morphogenesis (GO:0048813) | 2.90050227 |
| 59 | synaptic vesicle exocytosis (GO:0016079) | 2.89822731 |
| 60 | regulation of cell communication by electrical coupling (GO:0010649) | 2.89292399 |
| 61 | protein localization to synapse (GO:0035418) | 2.87506776 |
| 62 | positive regulation of synapse maturation (GO:0090129) | 2.87501751 |
| 63 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.87128595 |
| 64 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.86567703 |
| 65 | activation of protein kinase A activity (GO:0034199) | 2.86159580 |
| 66 | L-phenylalanine catabolic process (GO:0006559) | 2.85514038 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.85514038 |
| 68 | cardiac conduction (GO:0061337) | 2.84801268 |
| 69 | detection of calcium ion (GO:0005513) | 2.83642812 |
| 70 | blood coagulation, intrinsic pathway (GO:0007597) | 2.83640639 |
| 71 | regulation of sarcomere organization (GO:0060297) | 2.82798196 |
| 72 | response to pheromone (GO:0019236) | 2.80191640 |
| 73 | cardiac muscle cell development (GO:0055013) | 2.80054655 |
| 74 | cardiac muscle hypertrophy (GO:0003300) | 2.78778130 |
| 75 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.77695203 |
| 76 | relaxation of cardiac muscle (GO:0055119) | 2.76766212 |
| 77 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.76366354 |
| 78 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.76273780 |
| 79 | exploration behavior (GO:0035640) | 2.75058781 |
| 80 | neuron recognition (GO:0008038) | 2.74951778 |
| 81 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.74632984 |
| 82 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.74632984 |
| 83 | cardiac muscle cell action potential (GO:0086001) | 2.74256636 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 2.74206862 |
| 85 | macromolecular complex remodeling (GO:0034367) | 2.74206862 |
| 86 | plasma lipoprotein particle remodeling (GO:0034369) | 2.74206862 |
| 87 | glutamate secretion (GO:0014047) | 2.73099433 |
| 88 | negative regulation of sodium ion transport (GO:0010766) | 2.73062939 |
| 89 | protein-lipid complex assembly (GO:0065005) | 2.72927783 |
| 90 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.72649115 |
| 91 | COPII vesicle coating (GO:0048208) | 2.71984575 |
| 92 | innervation (GO:0060384) | 2.71111196 |
| 93 | striated muscle hypertrophy (GO:0014897) | 2.68198766 |
| 94 | cholesterol efflux (GO:0033344) | 2.67596082 |
| 95 | dendritic spine morphogenesis (GO:0060997) | 2.66728324 |
| 96 | cellular potassium ion homeostasis (GO:0030007) | 2.66294561 |
| 97 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.66140600 |
| 98 | neuron cell-cell adhesion (GO:0007158) | 2.64111968 |
| 99 | cardiac cell development (GO:0055006) | 2.63758146 |
| 100 | nucleus localization (GO:0051647) | 2.63584855 |
| 101 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.62628946 |
| 102 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.62572916 |
| 103 | L-phenylalanine metabolic process (GO:0006558) | 2.62572916 |
| 104 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.62420421 |
| 105 | regulation of apoptotic cell clearance (GO:2000425) | 2.61657430 |
| 106 | regulation of actin filament-based movement (GO:1903115) | 2.61037710 |
| 107 | membrane repolarization during action potential (GO:0086011) | 2.60693546 |
| 108 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.58968824 |
| 109 | C4-dicarboxylate transport (GO:0015740) | 2.58908708 |
| 110 | membrane repolarization (GO:0086009) | 2.58102670 |
| 111 | proline transport (GO:0015824) | 2.56986457 |
| 112 | positive regulation of potassium ion transport (GO:0043268) | 2.56913385 |
| 113 | actomyosin structure organization (GO:0031032) | 2.54938357 |
| 114 | neurotransmitter secretion (GO:0007269) | 2.53606407 |
| 115 | plasma lipoprotein particle clearance (GO:0034381) | 2.52244408 |
| 116 | adult heart development (GO:0007512) | 2.51898752 |
| 117 | nephron epithelium morphogenesis (GO:0072088) | 2.51350706 |
| 118 | nephron tubule morphogenesis (GO:0072078) | 2.51350706 |
| 119 | high-density lipoprotein particle remodeling (GO:0034375) | 2.49735030 |
| 120 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.48407523 |
| 121 | gamma-aminobutyric acid transport (GO:0015812) | 2.47985480 |
| 122 | regulation of relaxation of muscle (GO:1901077) | 2.47861807 |
| 123 | negative regulation of complement activation (GO:0045916) | 2.47159934 |
| 124 | regulation of the force of heart contraction (GO:0002026) | 2.47019560 |
| 125 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.46705693 |
| 126 | regulation of heart rate (GO:0002027) | 2.45588802 |
| 127 | regulation of synaptic vesicle transport (GO:1902803) | 2.44915205 |
| 128 | regulation of cardiac muscle contraction (GO:0055117) | 2.43138473 |
| 129 | potassium ion import (GO:0010107) | 2.42332322 |
| 130 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.42214463 |
| 131 | multicellular organismal signaling (GO:0035637) | 2.41650252 |
| 132 | reverse cholesterol transport (GO:0043691) | 2.41645181 |
| 133 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.40469472 |
| 134 | axon extension (GO:0048675) | 2.40356554 |
| 135 | negative regulation of potassium ion transport (GO:0043267) | 2.40283240 |
| 136 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.40066850 |
| 137 | glutamate receptor signaling pathway (GO:0007215) | 2.39977500 |
| 138 | peptidyl-glutamic acid modification (GO:0018200) | 2.38085551 |
| 139 | negative regulation of lipase activity (GO:0060192) | 2.37248686 |
| 140 | regulation of cholesterol esterification (GO:0010872) | 2.36569320 |
| 141 | plasma lipoprotein particle organization (GO:0071827) | 2.36482978 |
| 142 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.32234922 |
| 143 | peristalsis (GO:0030432) | 2.31931261 |
| 144 | paraxial mesoderm development (GO:0048339) | 2.31829375 |
| 145 | intestinal absorption (GO:0050892) | 2.30640340 |
| 146 | postsynaptic membrane organization (GO:0001941) | 2.27467229 |
| 147 | tonic smooth muscle contraction (GO:0014820) | 2.27009749 |
| 148 | regulation of bile acid biosynthetic process (GO:0070857) | 2.26830829 |
| 149 | low-density lipoprotein particle clearance (GO:0034383) | 2.25786672 |
| 150 | renal tubule morphogenesis (GO:0061333) | 2.24458027 |
| 151 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.23407019 |
| 152 | positive regulation of glycolytic process (GO:0045821) | 2.22858545 |
| 153 | collagen fibril organization (GO:0030199) | 2.21670666 |
| 154 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.21146639 |
| 155 | protein-lipid complex subunit organization (GO:0071825) | 2.20933006 |
| 156 | fibrinolysis (GO:0042730) | 2.17878512 |
| 157 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.17210754 |
| 158 | cell adhesion mediated by integrin (GO:0033627) | 2.14608709 |
| 159 | anterior/posterior axis specification, embryo (GO:0008595) | 2.10494018 |
| 160 | presynaptic membrane assembly (GO:0097105) | 2.07996621 |
| 161 | cell proliferation involved in metanephros development (GO:0072203) | 2.07994977 |
| 162 | negative regulation of astrocyte differentiation (GO:0048712) | 2.05624957 |
| 163 | regulation of phospholipase A2 activity (GO:0032429) | 2.04774742 |
| 164 | endocardial cushion development (GO:0003197) | 2.03356435 |
| 165 | positive regulation of neurological system process (GO:0031646) | 2.03118059 |
| 166 | negative regulation of wound healing (GO:0061045) | 2.02487509 |
| 167 | artery smooth muscle contraction (GO:0014824) | 2.02471790 |
| 168 | triglyceride homeostasis (GO:0070328) | 2.02444336 |
| 169 | acylglycerol homeostasis (GO:0055090) | 2.02444336 |
| 170 | positive regulation of dendritic spine development (GO:0060999) | 2.00576838 |
| 171 | lung epithelium development (GO:0060428) | 2.00229741 |
| 172 | glomerular visceral epithelial cell development (GO:0072015) | 2.00048185 |
| 173 | vascular smooth muscle contraction (GO:0014829) | 1.99740747 |
| 174 | positive regulation of hormone biosynthetic process (GO:0046886) | 1.99192087 |
| 175 | negative regulation of cholesterol transport (GO:0032375) | 1.98014555 |
| 176 | negative regulation of sterol transport (GO:0032372) | 1.98014555 |
| 177 | regulation of cholesterol homeostasis (GO:2000188) | 1.97219489 |
| 178 | neutral lipid catabolic process (GO:0046461) | 1.96005618 |
| 179 | acylglycerol catabolic process (GO:0046464) | 1.96005618 |
| 180 | negative regulation of hemostasis (GO:1900047) | 1.95662871 |
| 181 | negative regulation of blood coagulation (GO:0030195) | 1.95662871 |
| 182 | cell proliferation involved in kidney development (GO:0072111) | 1.95549747 |
| 183 | complement activation, alternative pathway (GO:0006957) | 1.95504537 |
| 184 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.94972575 |
| 185 | positive regulation of extracellular matrix organization (GO:1903055) | 1.94405860 |
| 186 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.94319414 |
| 187 | positive regulation of muscle hypertrophy (GO:0014742) | 1.94319414 |
| 188 | skin morphogenesis (GO:0043589) | 1.94265235 |
| 189 | sterol transport (GO:0015918) | 1.93715739 |
| 190 | cholesterol transport (GO:0030301) | 1.93715739 |
| 191 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 1.92477083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.84196486 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.90052264 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.37355571 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.27609617 |
| 5 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18453313 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18453313 |
| 7 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17637896 |
| 8 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.15776775 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13407914 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11361594 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.09567971 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09517803 |
| 13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.04680115 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.95333973 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93896442 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.92521257 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.91344780 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89287863 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87377023 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85248675 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84965547 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82790775 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75439488 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.72781565 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.70156013 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67221898 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64656088 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62014402 |
| 29 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61863142 |
| 30 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.61806230 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61609591 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60811741 |
| 33 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.58520065 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58375541 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57718362 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56913228 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.53752192 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52771283 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50914756 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50467897 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49326139 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48472397 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45660782 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44483542 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43921178 |
| 46 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43195364 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43037525 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42846741 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42375572 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40397299 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39564591 |
| 52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39361481 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39308629 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39107568 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39107568 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.37106207 |
| 57 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35004056 |
| 58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34788747 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34483678 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34346889 |
| 61 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33746401 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.33621095 |
| 63 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33166714 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32895110 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31794176 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31199250 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29998652 |
| 68 | * AR_19668381_ChIP-Seq_PC3_Human | 1.29680578 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27495345 |
| 70 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.27191548 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27152151 |
| 72 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.27006297 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26830115 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25487747 |
| 75 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.25420843 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25279839 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24552802 |
| 78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23542012 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22571400 |
| 80 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21733337 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21480250 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20846094 |
| 83 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20843259 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19698627 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.19320680 |
| 86 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18753497 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18024262 |
| 88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17038886 |
| 89 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16296468 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15876712 |
| 91 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.14452319 |
| 92 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.14420413 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13824054 |
| 94 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13660577 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13181346 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12893095 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12662847 |
| 98 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12368525 |
| 99 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.10428503 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.10315457 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09968667 |
| 102 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.09798884 |
| 103 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.09533335 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08905870 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08870966 |
| 106 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08870966 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07864848 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07845355 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07588435 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07429655 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06255106 |
| 112 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06255106 |
| 113 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05329639 |
| 114 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04995027 |
| 115 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04863975 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04610478 |
| 117 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04475662 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04473294 |
| 119 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04180112 |
| 120 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03649174 |
| 121 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03602909 |
| 122 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03323204 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03234292 |
| 124 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02080592 |
| 125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01956303 |
| 126 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01693288 |
| 127 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01273907 |
| 128 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00899684 |
| 129 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00695941 |
| 130 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00086047 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99779123 |
| 132 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99536721 |
| 133 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99051314 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97816789 |
| 135 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97598529 |
| 136 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95436774 |
| 137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95195298 |
| 138 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95123776 |
| 139 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95123776 |
| 140 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93554349 |
| 141 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93527991 |
| 142 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92125622 |
| 143 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90736081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.94793525 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.62383632 |
| 3 | MP0000751_myopathy | 3.42261373 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.21247550 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.11815582 |
| 6 | MP0003646_muscle_fatigue | 2.65481386 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.35283317 |
| 8 | MP0000566_synostosis | 2.32294728 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.29866557 |
| 10 | MP0004270_analgesia | 2.21900896 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.14569488 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.11221679 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.07722112 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.02829248 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 1.97553026 |
| 16 | MP0003880_abnormal_central_pattern | 1.89745808 |
| 17 | MP0003868_abnormal_feces_composition | 1.86591944 |
| 18 | MP0002063_abnormal_learning/memory/cond | 1.82926926 |
| 19 | MP0003195_calcinosis | 1.82759033 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.82242314 |
| 21 | MP0004233_abnormal_muscle_weight | 1.80266183 |
| 22 | MP0008775_abnormal_heart_ventricle | 1.77640077 |
| 23 | MP0005330_cardiomyopathy | 1.77056786 |
| 24 | MP0005360_urolithiasis | 1.74865989 |
| 25 | MP0002972_abnormal_cardiac_muscle | 1.72686260 |
| 26 | MP0004087_abnormal_muscle_fiber | 1.71375980 |
| 27 | MP0004085_abnormal_heartbeat | 1.69838131 |
| 28 | MP0009046_muscle_twitch | 1.68702300 |
| 29 | MP0005620_abnormal_muscle_contractility | 1.66496606 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.65328038 |
| 31 | MP0000749_muscle_degeneration | 1.64848010 |
| 32 | MP0004484_altered_response_of | 1.64446579 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.63503978 |
| 34 | MP0000778_abnormal_nervous_system | 1.62489558 |
| 35 | MP0000569_abnormal_digit_pigmentation | 1.60429857 |
| 36 | MP0009745_abnormal_behavioral_response | 1.59258090 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.57748545 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.56979477 |
| 39 | MP0003123_paternal_imprinting | 1.56292647 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.55631563 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.55312213 |
| 42 | MP0002938_white_spotting | 1.54073586 |
| 43 | MP0004130_abnormal_muscle_cell | 1.52583286 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.52516297 |
| 45 | MP0006138_congestive_heart_failure | 1.48773257 |
| 46 | MP0005365_abnormal_bile_salt | 1.46760957 |
| 47 | MP0003941_abnormal_skin_development | 1.46095311 |
| 48 | MP0004858_abnormal_nervous_system | 1.45636572 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.41209889 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.40288154 |
| 51 | MP0002064_seizures | 1.39398286 |
| 52 | MP0003122_maternal_imprinting | 1.37633120 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.37110659 |
| 54 | MP0003942_abnormal_urinary_system | 1.37085371 |
| 55 | MP0001486_abnormal_startle_reflex | 1.36660882 |
| 56 | MP0002234_abnormal_pharynx_morphology | 1.35207497 |
| 57 | MP0002184_abnormal_innervation | 1.33703748 |
| 58 | MP0010630_abnormal_cardiac_muscle | 1.32680714 |
| 59 | MP0005385_cardiovascular_system_phenoty | 1.31167668 |
| 60 | MP0001544_abnormal_cardiovascular_syste | 1.31167668 |
| 61 | MP0005503_abnormal_tendon_morphology | 1.30759415 |
| 62 | MP0006054_spinal_hemorrhage | 1.30608408 |
| 63 | MP0004885_abnormal_endolymph | 1.29199659 |
| 64 | MP0005670_abnormal_white_adipose | 1.27540529 |
| 65 | MP0002106_abnormal_muscle_physiology | 1.26974413 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.26281830 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.25317902 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.24955448 |
| 69 | MP0005187_abnormal_penis_morphology | 1.24839585 |
| 70 | MP0002269_muscular_atrophy | 1.24759324 |
| 71 | MP0003937_abnormal_limbs/digits/tail_de | 1.22957962 |
| 72 | MP0004924_abnormal_behavior | 1.21134327 |
| 73 | MP0005386_behavior/neurological_phenoty | 1.21134327 |
| 74 | MP0005408_hypopigmentation | 1.20733407 |
| 75 | MP0002272_abnormal_nervous_system | 1.20335897 |
| 76 | MP0001299_abnormal_eye_distance/ | 1.19728584 |
| 77 | MP0005248_abnormal_Harderian_gland | 1.18987414 |
| 78 | MP0002067_abnormal_sensory_capabilities | 1.15917476 |
| 79 | MP0005369_muscle_phenotype | 1.15801273 |
| 80 | MP0003787_abnormal_imprinting | 1.14789813 |
| 81 | MP0002233_abnormal_nose_morphology | 1.13737686 |
| 82 | MP0003252_abnormal_bile_duct | 1.13628566 |
| 83 | MP0004811_abnormal_neuron_physiology | 1.13017111 |
| 84 | MP0001984_abnormal_olfaction | 1.11933643 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 1.10425019 |
| 86 | MP0000750_abnormal_muscle_regeneration | 1.09701653 |
| 87 | MP0001529_abnormal_vocalization | 1.08796664 |
| 88 | MP0002822_catalepsy | 1.08739401 |
| 89 | MP0002108_abnormal_muscle_morphology | 1.08506619 |
| 90 | MP0002653_abnormal_ependyma_morphology | 1.08378511 |
| 91 | MP0005646_abnormal_pituitary_gland | 1.06833396 |
| 92 | MP0005409_darkened_coat_color | 1.05902968 |
| 93 | MP0000955_abnormal_spinal_cord | 1.04275402 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 1.02899937 |
| 95 | MP0000759_abnormal_skeletal_muscle | 1.02579096 |
| 96 | MP0008569_lethality_at_weaning | 1.01876338 |
| 97 | MP0002733_abnormal_thermal_nociception | 1.01364621 |
| 98 | MP0000762_abnormal_tongue_morphology | 1.00530571 |
| 99 | MP0002127_abnormal_cardiovascular_syste | 1.00174278 |
| 100 | MP0006276_abnormal_autonomic_nervous | 1.00167068 |
| 101 | MP0009384_cardiac_valve_regurgitation | 1.00139823 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.98980152 |
| 103 | MP0003755_abnormal_palate_morphology | 0.97199579 |
| 104 | MP0000747_muscle_weakness | 0.97159103 |
| 105 | MP0004510_myositis | 0.96937307 |
| 106 | MP0001440_abnormal_grooming_behavior | 0.96887542 |
| 107 | MP0001915_intracranial_hemorrhage | 0.96830327 |
| 108 | MP0002557_abnormal_social/conspecific_i | 0.96807114 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.96713181 |
| 110 | MP0002882_abnormal_neuron_morphology | 0.96002127 |
| 111 | MP0002282_abnormal_trachea_morphology | 0.94957990 |
| 112 | MP0009697_abnormal_copulation | 0.94436615 |
| 113 | MP0001970_abnormal_pain_threshold | 0.94410496 |
| 114 | MP0005410_abnormal_fertilization | 0.94315526 |
| 115 | MP0006072_abnormal_retinal_apoptosis | 0.93876260 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.93629746 |
| 117 | MP0002736_abnormal_nociception_after | 0.93498122 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.92799318 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.92688423 |
| 120 | MP0004272_abnormal_basement_membrane | 0.92280102 |
| 121 | MP0005275_abnormal_skin_tensile | 0.92023774 |
| 122 | MP0003115_abnormal_respiratory_system | 0.91214288 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.89768999 |
| 124 | MP0003283_abnormal_digestive_organ | 0.89017868 |
| 125 | MP0003385_abnormal_body_wall | 0.88672348 |
| 126 | MP0001270_distended_abdomen | 0.88355989 |
| 127 | MP0001958_emphysema | 0.87748229 |
| 128 | MP0001177_atelectasis | 0.85597621 |
| 129 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85449480 |
| 130 | MP0002971_abnormal_brown_adipose | 0.85010608 |
| 131 | MP0002152_abnormal_brain_morphology | 0.84101572 |
| 132 | MP0003566_abnormal_cell_adhesion | 0.83292890 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.80815113 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.79743989 |
| 135 | MP0010030_abnormal_orbit_morphology | 0.79325495 |
| 136 | MP0002066_abnormal_motor_capabilities/c | 0.77873463 |
| 137 | MP0003121_genomic_imprinting | 0.77746976 |
| 138 | MP0002697_abnormal_eye_size | 0.76259422 |
| 139 | MP0003045_fibrosis | 0.75517143 |
| 140 | MP0003315_abnormal_perineum_morphology | 0.74404911 |
| 141 | MP0000631_abnormal_neuroendocrine_gland | 0.73759219 |
| 142 | MP0009053_abnormal_anal_canal | 0.73580377 |
| 143 | MP0000639_abnormal_adrenal_gland | 0.73524606 |
| 144 | MP0001286_abnormal_eye_development | 0.73222280 |
| 145 | MP0000266_abnormal_heart_morphology | 0.71821261 |
| 146 | MP0003279_aneurysm | 0.71350264 |
| 147 | MP0001661_extended_life_span | 0.71272084 |
| 148 | MP0006292_abnormal_olfactory_placode | 0.71076752 |
| 149 | MP0002116_abnormal_craniofacial_bone | 0.70514809 |
| 150 | MP0000163_abnormal_cartilage_morphology | 0.69991111 |
| 151 | MP0002115_abnormal_skeleton_extremities | 0.69681178 |
| 152 | MP0002109_abnormal_limb_morphology | 0.69011870 |
| 153 | MP0001502_abnormal_circadian_rhythm | 0.67552838 |
| 154 | MP0000049_abnormal_middle_ear | 0.66777907 |
| 155 | MP0002160_abnormal_reproductive_system | 0.66314358 |
| 156 | MP0003861_abnormal_nervous_system | 0.66099877 |
| 157 | MP0004134_abnormal_chest_morphology | 0.65777798 |
| 158 | MP0000432_abnormal_head_morphology | 0.65552338 |
| 159 | MP0002876_abnormal_thyroid_physiology | 0.65492508 |
| 160 | MP0003633_abnormal_nervous_system | 0.64874548 |
| 161 | MP0003935_abnormal_craniofacial_develop | 0.64448847 |
| 162 | MP0000428_abnormal_craniofacial_morphol | 0.64385042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.28198886 |
| 2 | Sudden death (HP:0001699) | 4.81960720 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.31442778 |
| 4 | Atrial fibrillation (HP:0005110) | 3.95757546 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 3.78486831 |
| 6 | Supraventricular tachycardia (HP:0004755) | 3.54730281 |
| 7 | Supraventricular arrhythmia (HP:0005115) | 3.51374356 |
| 8 | Prolonged QT interval (HP:0001657) | 3.49662399 |
| 9 | Bundle branch block (HP:0011710) | 3.48915047 |
| 10 | Syncope (HP:0001279) | 3.44640711 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 3.28699702 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 3.27818416 |
| 13 | Small epiphyses (HP:0010585) | 3.07964372 |
| 14 | Ventricular fibrillation (HP:0001663) | 3.06041201 |
| 15 | Vascular tortuosity (HP:0004948) | 3.01889494 |
| 16 | Ventricular tachycardia (HP:0004756) | 2.99695783 |
| 17 | Exercise-induced myalgia (HP:0003738) | 2.96731944 |
| 18 | Focal motor seizures (HP:0011153) | 2.92559769 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 2.91324299 |
| 20 | Abnormality of carpal bone ossification (HP:0006257) | 2.89221610 |
| 21 | Arterial tortuosity (HP:0005116) | 2.86129074 |
| 22 | Complement deficiency (HP:0004431) | 2.83424086 |
| 23 | Action tremor (HP:0002345) | 2.79804558 |
| 24 | Myokymia (HP:0002411) | 2.78307598 |
| 25 | Ventricular arrhythmia (HP:0004308) | 2.74573663 |
| 26 | Cardiovascular calcification (HP:0011915) | 2.74178320 |
| 27 | Premature rupture of membranes (HP:0001788) | 2.73950416 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 2.73032707 |
| 29 | Focal seizures (HP:0007359) | 2.70952546 |
| 30 | Neonatal short-limb short stature (HP:0008921) | 2.65886094 |
| 31 | Hyporeflexia of lower limbs (HP:0002600) | 2.65422778 |
| 32 | Abnormal EKG (HP:0003115) | 2.64964229 |
| 33 | Broad palm (HP:0001169) | 2.64870953 |
| 34 | Aortic dissection (HP:0002647) | 2.61380651 |
| 35 | Aortic aneurysm (HP:0004942) | 2.61259520 |
| 36 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.61154855 |
| 37 | Termporal pattern (HP:0011008) | 2.59805910 |
| 38 | Insidious onset (HP:0003587) | 2.59805910 |
| 39 | Lipoatrophy (HP:0100578) | 2.57352060 |
| 40 | Vascular calcification (HP:0004934) | 2.55146885 |
| 41 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.52550500 |
| 42 | Subaortic stenosis (HP:0001682) | 2.52550500 |
| 43 | Central scotoma (HP:0000603) | 2.52279005 |
| 44 | Progressive cerebellar ataxia (HP:0002073) | 2.51785402 |
| 45 | Right ventricular cardiomyopathy (HP:0011663) | 2.51784265 |
| 46 | Dysmetric saccades (HP:0000641) | 2.51709862 |
| 47 | Exercise-induced muscle cramps (HP:0003710) | 2.49641898 |
| 48 | Joint hemorrhage (HP:0005261) | 2.49127773 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.48946832 |
| 50 | Broad metatarsal (HP:0001783) | 2.48743154 |
| 51 | Abnormal hand bone ossification (HP:0010660) | 2.46204172 |
| 52 | Arthropathy (HP:0003040) | 2.45159070 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44016511 |
| 54 | Mitral stenosis (HP:0001718) | 2.40544471 |
| 55 | Genetic anticipation (HP:0003743) | 2.35908633 |
| 56 | Heart block (HP:0012722) | 2.35228741 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.35123777 |
| 58 | Epidermoid cyst (HP:0200040) | 2.33150105 |
| 59 | Alacrima (HP:0000522) | 2.32485184 |
| 60 | Hypercholesterolemia (HP:0003124) | 2.29632918 |
| 61 | Visual hallucinations (HP:0002367) | 2.29198146 |
| 62 | Coronal craniosynostosis (HP:0004440) | 2.28003795 |
| 63 | Febrile seizures (HP:0002373) | 2.26121365 |
| 64 | Epileptic encephalopathy (HP:0200134) | 2.26007267 |
| 65 | Broad alveolar ridges (HP:0000187) | 2.23501330 |
| 66 | Difficulty running (HP:0009046) | 2.21704554 |
| 67 | Spontaneous abortion (HP:0005268) | 2.19923386 |
| 68 | Abnormality of the lower motor neuron (HP:0002366) | 2.19674428 |
| 69 | Abnormal atrioventricular conduction (HP:0005150) | 2.18514861 |
| 70 | Abnormality of the nasal septum (HP:0000419) | 2.18401663 |
| 71 | Soft skin (HP:0000977) | 2.16002888 |
| 72 | Shallow orbits (HP:0000586) | 2.14210891 |
| 73 | Decreased lacrimation (HP:0000633) | 2.13498808 |
| 74 | Myotonia (HP:0002486) | 2.13394063 |
| 75 | Abnormal ossification of hand bones (HP:0005921) | 2.12232816 |
| 76 | Abnormality of dentin (HP:0010299) | 2.11701144 |
| 77 | Epiphyseal dysplasia (HP:0002656) | 2.10877218 |
| 78 | Pheochromocytoma (HP:0002666) | 2.08450604 |
| 79 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.07108226 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 2.06155707 |
| 81 | Left ventricular hypertrophy (HP:0001712) | 2.05701727 |
| 82 | Abnormality of the wing of the ilium (HP:0011867) | 2.04892270 |
| 83 | Atrioventricular block (HP:0001678) | 2.01535254 |
| 84 | Microglossia (HP:0000171) | 2.00563606 |
| 85 | Lymphangioma (HP:0100764) | 1.99040548 |
| 86 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.98542242 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 1.97346136 |
| 88 | Increased connective tissue (HP:0009025) | 1.97321090 |
| 89 | Abnormality of complement system (HP:0005339) | 1.96596240 |
| 90 | Papillary thyroid carcinoma (HP:0002895) | 1.96542929 |
| 91 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.96381865 |
| 92 | Lower limb amyotrophy (HP:0007210) | 1.95433699 |
| 93 | Excessive salivation (HP:0003781) | 1.93278014 |
| 94 | Drooling (HP:0002307) | 1.93278014 |
| 95 | Renal duplication (HP:0000075) | 1.93081711 |
| 96 | EMG: myopathic abnormalities (HP:0003458) | 1.92866306 |
| 97 | Buphthalmos (HP:0000557) | 1.91359406 |
| 98 | Broad-based gait (HP:0002136) | 1.91177000 |
| 99 | Limited elbow extension (HP:0001377) | 1.90505470 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 1.88614445 |
| 101 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.88237911 |
| 102 | Abnormal tarsal ossification (HP:0008369) | 1.87599098 |
| 103 | Rhizomelia (HP:0008905) | 1.86927297 |
| 104 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.86549736 |
| 105 | Dysdiadochokinesis (HP:0002075) | 1.85357366 |
| 106 | Supernumerary spleens (HP:0009799) | 1.85175696 |
| 107 | Dilated cardiomyopathy (HP:0001644) | 1.84958133 |
| 108 | Bladder diverticulum (HP:0000015) | 1.83360244 |
| 109 | Overgrowth (HP:0001548) | 1.82226282 |
| 110 | Renovascular hypertension (HP:0100817) | 1.81858321 |
| 111 | Palpitations (HP:0001962) | 1.81271715 |
| 112 | Hypothermia (HP:0002045) | 1.81052811 |
| 113 | Abnormality of the acetabulum (HP:0003170) | 1.80899033 |
| 114 | Abnormal delivery (HP:0001787) | 1.80782062 |
| 115 | Scotoma (HP:0000575) | 1.79931401 |
| 116 | Absence seizures (HP:0002121) | 1.79184717 |
| 117 | Atonic seizures (HP:0010819) | 1.79117786 |
| 118 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78526068 |
| 119 | Neoplasm of the heart (HP:0100544) | 1.78255789 |
| 120 | Intrahepatic cholestasis (HP:0001406) | 1.77523943 |
| 121 | Follicular hyperkeratosis (HP:0007502) | 1.77310338 |
| 122 | Abnormality of the intrinsic pathway (HP:0010989) | 1.77015932 |
| 123 | Menorrhagia (HP:0000132) | 1.76969288 |
| 124 | Xanthomatosis (HP:0000991) | 1.76953508 |
| 125 | Protrusio acetabuli (HP:0003179) | 1.76377783 |
| 126 | Wide anterior fontanel (HP:0000260) | 1.76027935 |
| 127 | Hamartoma of the eye (HP:0010568) | 1.75875948 |
| 128 | Enlarged kidneys (HP:0000105) | 1.74931542 |
| 129 | Ulnar claw (HP:0001178) | 1.74350754 |
| 130 | Flared iliac wings (HP:0002869) | 1.73349299 |
| 131 | Hypoventilation (HP:0002791) | 1.73339986 |
| 132 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.73082864 |
| 133 | Cerebral aneurysm (HP:0004944) | 1.72114628 |
| 134 | Depression (HP:0000716) | 1.71834428 |
| 135 | Hypoplastic ischia (HP:0003175) | 1.71770644 |
| 136 | Atrophic scars (HP:0001075) | 1.71528861 |
| 137 | Acanthocytosis (HP:0001927) | 1.69823177 |
| 138 | Generalized tonic-clonic seizures (HP:0002069) | 1.69461629 |
| 139 | Midline defect of the nose (HP:0004122) | 1.69197760 |
| 140 | Glomerulonephritis (HP:0000099) | 1.68486894 |
| 141 | Irregular epiphyses (HP:0010582) | 1.68061064 |
| 142 | Neuroendocrine neoplasm (HP:0100634) | 1.68054657 |
| 143 | Hypoalphalipoproteinemia (HP:0003233) | 1.67593098 |
| 144 | Myoglobinuria (HP:0002913) | 1.67576004 |
| 145 | Abnormality of the 4th metacarpal (HP:0010012) | 1.67377530 |
| 146 | Wide nose (HP:0000445) | 1.65886160 |
| 147 | Limited hip movement (HP:0008800) | 1.65739579 |
| 148 | Elfin facies (HP:0004428) | 1.65310868 |
| 149 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65127224 |
| 150 | Gaze-evoked nystagmus (HP:0000640) | 1.63644833 |
| 151 | Torticollis (HP:0000473) | 1.63217450 |
| 152 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.63091855 |
| 153 | Absent epiphyses (HP:0010577) | 1.63091855 |
| 154 | Bradycardia (HP:0001662) | 1.62982938 |
| 155 | Abnormal social behavior (HP:0012433) | 1.62560924 |
| 156 | Impaired social interactions (HP:0000735) | 1.62560924 |
| 157 | Hepatoblastoma (HP:0002884) | 1.62040975 |
| 158 | Wormian bones (HP:0002645) | 1.61953880 |
| 159 | Poor eye contact (HP:0000817) | 1.61912330 |
| 160 | Type 1 muscle fiber predominance (HP:0003803) | 1.61424428 |
| 161 | Hammertoe (HP:0001765) | 1.61117591 |
| 162 | Postural instability (HP:0002172) | 1.60665079 |
| 163 | Flat cornea (HP:0007720) | 1.59281103 |
| 164 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.59082074 |
| 165 | Ankle contracture (HP:0006466) | 1.57947384 |
| 166 | Skin nodule (HP:0200036) | 1.57599896 |
| 167 | Hypoglycemic coma (HP:0001325) | 1.57124273 |
| 168 | Enlarged penis (HP:0000040) | 1.57056787 |
| 169 | Abnormality of the foot musculature (HP:0001436) | 1.56239160 |
| 170 | Macroorchidism (HP:0000053) | 1.55727839 |
| 171 | Prominent supraorbital ridges (HP:0000336) | 1.55397618 |
| 172 | Advanced eruption of teeth (HP:0006288) | 1.54840615 |
| 173 | Pointed chin (HP:0000307) | 1.53833082 |
| 174 | Neonatal death (HP:0003811) | 1.53262029 |
| 175 | Heterotopia (HP:0002282) | 1.53024158 |
| 176 | Abnormality of the pubic bones (HP:0003172) | 1.52927883 |
| 177 | Overlapping toe (HP:0001845) | 1.52575613 |
| 178 | Morphological abnormality of the middle ear (HP:0008609) | 1.51057454 |
| 179 | Coxa vara (HP:0002812) | 1.49438521 |
| 180 | Asymmetry of the thorax (HP:0001555) | 1.49122242 |
| 181 | Facial shape deformation (HP:0011334) | 1.48340040 |
| 182 | Potter facies (HP:0002009) | 1.48340040 |
| 183 | Cervical subluxation (HP:0003308) | 1.47728840 |
| 184 | Impaired pain sensation (HP:0007328) | 1.46973643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.09224688 |
| 2 | AKT3 | 2.78081637 |
| 3 | NTRK3 | 2.67240042 |
| 4 | MAP3K4 | 2.63369880 |
| 5 | PHKG1 | 2.57024689 |
| 6 | PHKG2 | 2.57024689 |
| 7 | LMTK2 | 2.34827200 |
| 8 | PDK3 | 2.25529306 |
| 9 | PDK4 | 2.25529306 |
| 10 | EPHA4 | 2.15569573 |
| 11 | PAK6 | 2.03296204 |
| 12 | MAP3K9 | 2.02480506 |
| 13 | PRKD3 | 2.01377110 |
| 14 | BCR | 2.00512277 |
| 15 | TTN | 2.00219061 |
| 16 | LATS2 | 1.99349061 |
| 17 | FGFR3 | 1.98101526 |
| 18 | LATS1 | 1.83584906 |
| 19 | DMPK | 1.73858383 |
| 20 | PKN2 | 1.73375660 |
| 21 | MET | 1.65399032 |
| 22 | MINK1 | 1.62011032 |
| 23 | TRIB3 | 1.58051423 |
| 24 | PAK3 | 1.53872575 |
| 25 | FGFR4 | 1.51611909 |
| 26 | CAMKK1 | 1.50607793 |
| 27 | KSR1 | 1.50532386 |
| 28 | MAP2K7 | 1.50103122 |
| 29 | RIPK1 | 1.49999379 |
| 30 | STK38 | 1.47183474 |
| 31 | WNK3 | 1.45203767 |
| 32 | NEK1 | 1.41989600 |
| 33 | MST1R | 1.41632069 |
| 34 | CAMK1G | 1.41098156 |
| 35 | MAP2K4 | 1.36898514 |
| 36 | KSR2 | 1.35619169 |
| 37 | MAPK13 | 1.30946942 |
| 38 | PDGFRA | 1.30731279 |
| 39 | NTRK2 | 1.30379737 |
| 40 | DDR2 | 1.25996367 |
| 41 | DAPK2 | 1.25964323 |
| 42 | STK39 | 1.21955469 |
| 43 | INSRR | 1.21715171 |
| 44 | BMPR1B | 1.19007028 |
| 45 | RET | 1.17635903 |
| 46 | FRK | 1.16302910 |
| 47 | FER | 1.08529179 |
| 48 | TRIM28 | 1.08466883 |
| 49 | OBSCN | 1.07105093 |
| 50 | CDK12 | 1.06115785 |
| 51 | STK3 | 1.05457045 |
| 52 | MAP3K12 | 1.04651393 |
| 53 | CDC42BPA | 1.02964034 |
| 54 | PTK2 | 1.02274214 |
| 55 | BRD4 | 1.01299964 |
| 56 | PDK2 | 1.00261772 |
| 57 | PINK1 | 0.96665818 |
| 58 | ERBB4 | 0.96248072 |
| 59 | ROCK1 | 0.96092587 |
| 60 | PLK2 | 0.94834029 |
| 61 | CAMK1D | 0.92866705 |
| 62 | ICK | 0.91772071 |
| 63 | CDK5 | 0.91449178 |
| 64 | TAOK1 | 0.91064725 |
| 65 | MYLK | 0.90665229 |
| 66 | SIK1 | 0.89924063 |
| 67 | SGK2 | 0.89786173 |
| 68 | SIK2 | 0.89132356 |
| 69 | PAK2 | 0.87616103 |
| 70 | TYRO3 | 0.87602563 |
| 71 | CAMK2A | 0.85978744 |
| 72 | NTRK1 | 0.85314719 |
| 73 | PIK3CA | 0.85266103 |
| 74 | SGK3 | 0.85141320 |
| 75 | CASK | 0.85095789 |
| 76 | EPHA3 | 0.83196983 |
| 77 | PRKAA1 | 0.82417428 |
| 78 | PLK4 | 0.82257526 |
| 79 | WNK1 | 0.80778317 |
| 80 | PTK2B | 0.80475355 |
| 81 | NEK9 | 0.79622726 |
| 82 | ERBB3 | 0.78929931 |
| 83 | CSNK1A1L | 0.78583917 |
| 84 | TGFBR2 | 0.76435190 |
| 85 | PNCK | 0.76282080 |
| 86 | SGK494 | 0.76123081 |
| 87 | SGK223 | 0.76123081 |
| 88 | MARK2 | 0.76101194 |
| 89 | CAMK2D | 0.75242212 |
| 90 | EPHB2 | 0.74154872 |
| 91 | CSNK1G1 | 0.73265701 |
| 92 | CAMK4 | 0.72769510 |
| 93 | MAP3K7 | 0.72724812 |
| 94 | FGFR2 | 0.70210565 |
| 95 | CSNK1E | 0.70184819 |
| 96 | MAP3K6 | 0.70167697 |
| 97 | FLT3 | 0.68854066 |
| 98 | UHMK1 | 0.66847866 |
| 99 | STK11 | 0.66688140 |
| 100 | PRKCG | 0.65502806 |
| 101 | CAMK1 | 0.65364419 |
| 102 | PRKD1 | 0.64649252 |
| 103 | CDK3 | 0.63694918 |
| 104 | PRKCH | 0.62534118 |
| 105 | MAP4K2 | 0.61946969 |
| 106 | PRKCE | 0.61540873 |
| 107 | STK38L | 0.60095159 |
| 108 | EIF2AK1 | 0.58618148 |
| 109 | SGK1 | 0.58213274 |
| 110 | RPS6KA2 | 0.58094249 |
| 111 | MAP3K2 | 0.57276294 |
| 112 | PLK3 | 0.54198306 |
| 113 | BRSK2 | 0.54136832 |
| 114 | CSNK1G2 | 0.53061719 |
| 115 | TNIK | 0.52647374 |
| 116 | PRKAA2 | 0.51958652 |
| 117 | NEK2 | 0.51954604 |
| 118 | GRK5 | 0.51769431 |
| 119 | RPS6KA3 | 0.50999270 |
| 120 | CDK8 | 0.49836872 |
| 121 | STK24 | 0.49587863 |
| 122 | PRKG1 | 0.48452530 |
| 123 | WNK4 | 0.48191132 |
| 124 | PRKCZ | 0.47414375 |
| 125 | CAMKK2 | 0.46973739 |
| 126 | PDGFRB | 0.46581200 |
| 127 | PKN1 | 0.46145300 |
| 128 | ROCK2 | 0.45886416 |
| 129 | NUAK1 | 0.45654312 |
| 130 | ERBB2 | 0.44587312 |
| 131 | BRSK1 | 0.44314635 |
| 132 | EIF2AK3 | 0.43767815 |
| 133 | CSNK1D | 0.43693287 |
| 134 | FGFR1 | 0.43566488 |
| 135 | MAPKAPK5 | 0.42911794 |
| 136 | MKNK2 | 0.40074096 |
| 137 | MTOR | 0.39762784 |
| 138 | DYRK1A | 0.39557039 |
| 139 | CDK18 | 0.39321062 |
| 140 | MUSK | 0.38462116 |
| 141 | PDK1 | 0.38345184 |
| 142 | PRKACB | 0.38197209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.03401445 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.41070493 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.17354402 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.12928969 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.10488365 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.09340064 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08995692 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.02446991 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.91248218 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.90505173 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.90081558 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84260918 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.82034137 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.81768054 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.81347833 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72888297 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.72435668 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.72407799 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.72049306 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.70871734 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.60798967 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.58538368 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.57492906 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.55397584 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54549335 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53456039 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53130082 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49090230 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.48126747 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47740498 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.44018388 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.43776931 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38867104 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38315776 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.37985058 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35895096 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35230690 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.34662193 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34261005 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29957045 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27692962 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 1.27579051 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27169946 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25442320 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25436847 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24695148 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24043714 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23768953 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23664186 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22444754 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22419842 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.21706531 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 1.18953307 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15962866 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.13757109 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12644936 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11346022 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09790699 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.09422788 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08998774 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08226559 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08142161 |
| 63 | Glioma_Homo sapiens_hsa05214 | 1.07081019 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05011249 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.03637006 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03270533 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01820705 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01470870 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 1.01232793 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01078833 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00288748 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99832827 |
| 73 | Melanogenesis_Homo sapiens_hsa04916 | 0.99194347 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98521776 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96297565 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93788911 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93438339 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.92894307 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92789322 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91685096 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91216076 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90817170 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90255522 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89551573 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88774567 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86157970 |
| 87 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.84960319 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84867956 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83975379 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.83379402 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81014846 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80314422 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79519396 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79344971 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78280807 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77751337 |
| 97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77592391 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77254680 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76702439 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75047605 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.73531718 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72065864 |
| 103 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71493651 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71390743 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.70075812 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67130137 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67016774 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65219689 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.65018730 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65016842 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64845424 |
| 112 | Phototransduction_Homo sapiens_hsa04744 | 0.64745297 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64710608 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63983797 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.63813754 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.63807351 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63482753 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.63327540 |
| 119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62820158 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62495356 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62063390 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61981787 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61931631 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60216891 |
| 125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59867486 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.59284188 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58730704 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58397910 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58364429 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57912078 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57799585 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56776087 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55134315 |
| 134 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54657127 |
| 135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54604001 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54378917 |
| 137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52708881 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52367928 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52159423 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51888059 |
| 141 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50671689 |
| 142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49987489 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.49218065 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48898763 |
| 145 | Protein export_Homo sapiens_hsa03060 | 0.48727295 |
| 146 | Amoebiasis_Homo sapiens_hsa05146 | 0.47417818 |
| 147 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44965020 |
| 148 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42927042 |

